Page 7 - குழு க்கு ஆர்ஃபந் மருத்துவ ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Our six dermatology products are marketed by our partner company, Journey Medical Corporation (“Journey”). Our products generated net revenues of $44.5 million for full-year 2020, compared to full-year 2019 net revenues of $34.9 million, representing growth of 28%. Our products generated $13.7 million in revenues in the fourth quarter of 2020, compared to $11.1 million in the fourth quarter of 2019, representing growth of 23%. While we generated revenue growth year-over-year in 2020, sales of our products were impacted by the COVID-19 pandemic, which caused a temporary supply shortage and impacted the ability of our sales force to make in person calls, due to states slowly re-opening. We in-licensed and recently launched our sixth prescription dermatology product.

United statesFred hutchSamsung biologicsLindsaya rosenwaldInternational symposium on amyloidosisAmerican society of hematology annual meetingProstate cancer foundation scientificTrademark officeCommittee for orphan medicinal productsEuropean society for medical oncology virtual congressHealth technology assessmentsMadison pharmaceuticals incCaelum biosciences incFred hutchinson cancer research center hutchSociety for immunotherapy of cancerCheckpoint therapeutics inc